Stock Events

Stock Events

ETHZilla 

$5.88
120
-$0.24-3.9% Wednesday 17:40

Statistics

Day High
6.3
Day Low
5.88
52W High
174.6
52W Low
2.8
Volume
988,127
Avg. Volume
-
Mkt Cap
125.85M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

3JunExpected
Q4 2023
Q2 2024
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-228
-157.6
-87.2
-16.8
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-28.36MNet Income

Analyst Ratings

9.00Average Price Target
The highest estimate is 9.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is involved in gene editing, a cutting-edge area of biotechnology that could compete with 180 Life Sciences' novel therapeutic approaches.
Editas Medicine
EDIT
Mkt Cap485.31M
Editas Medicine operates in the genome editing space, directly competing with 180 Life Sciences in developing treatments for diseases with unmet medical needs.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is another key player in the CRISPR/Cas9 technology sector, potentially competing with 180 Life Sciences in the field of genetic and autoimmune diseases.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals focuses on creating transformative medicines for people with serious diseases, which aligns with 180 Life Sciences' mission, making them competitors.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is known for its innovation in biotechnology, competing with 180 Life Sciences in developing novel therapeutics for various diseases.
Alnylam Pharmaceuticals
ALNY
Mkt Cap31.73B
Alnylam Pharmaceuticals is a leader in RNAi therapeutics, competing with 180 Life Sciences in the development of novel treatments for genetic and other diseases.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.52B
BioMarin Pharmaceutical focuses on enzyme replacement therapies and other innovative treatments for rare genetic diseases, competing with 180 Life Sciences in the rare disease space.
Sarepta Therapeutics
SRPT
Mkt Cap2.2B
Sarepta Therapeutics is focused on the discovery and development of RNA-based therapeutics, competing with 180 Life Sciences in the development of innovative treatments for diseases.

About

ETHZilla operates in digital asset management, gaming, and entertainment. The Company is developing an Ether (ETH) accumulation vehicle to serve as a benchmark for on-chain treasury management among public companies, supported by Electric Capital and a DeFi Council of industry experts. Its strategy targets yield generation beyond traditional ETH staking while advancing gaming initiatives and pursuing monetization of legacy biotechnology assets from its origins as a biotech company.
Show more...
CEO
Mr. McAndrew Rudisill BA(Econ)
Employees
4
Country
United States
ISIN
US68236V3024

Listings

F
DE
L270.F
BOATS
BOATS
ETHZ.BOATS
XNAS
US
FRMM

0 Comments

Share your thoughts

FAQ

What is ETHZilla stock price today?▼
The current price of ETHZ is $5.88 USD — it has decreased by -3.9% in the past 24 hours. Watch ETHZilla stock price performance more closely on the chart.
What is ETHZilla stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange ETHZilla stocks are traded under the ticker ETHZ.
Is ETHZilla stock price growing?▼
ETHZ stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year ETHZilla has showed a -74.54% decrease.
What is ETHZilla market cap?▼
Today ETHZilla has the market capitalization of 125.85M
What is ETHZilla revenue for the last year?▼
ETHZilla revenue for the last year amounts to 0 USD.
What is ETHZilla net income for the last year?▼
ETHZ net income for the last year is -28.36M USD.
How many employees does ETHZilla have?▼
As of September 06, 2026, the company has 4 employees.
In which sector is ETHZilla located?▼
ETHZilla operates in the Other sector.
When did ETHZilla complete a stock split?▼
The last stock split for ETHZilla was on October 20, 2025 with a ratio of 1:10.
Where is ETHZilla headquartered?▼
ETHZilla is headquartered in Palm Beach, United States.